{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T04:51:40Z","timestamp":1764996700838,"version":"3.37.3"},"reference-count":32,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2003,4,1]],"date-time":"2003-04-01T00:00:00Z","timestamp":1049155200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2003,4,1]],"date-time":"2003-04-01T00:00:00Z","timestamp":1049155200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2003,4]]},"DOI":"10.1124\/dmd.31.4.462","type":"journal-article","created":{"date-parts":[[2003,3,18]],"date-time":"2003-03-18T11:14:00Z","timestamp":1047986040000},"page":"462-468","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Modeling the Metabolism of Idarubicin to Idarubicinol in Rat Heart: Effect of Rutin and Phenobarbital"],"prefix":"10.1016","volume":"31","author":[{"given":"Wonku","family":"Kang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.31.4.462_bib1","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1211\/0022357991777010","article-title":"Inhibition of aldo-keto reductases by phenobarbital alters metabolism, pharmacokinetics and toxicity of doxorubicin in rats.","volume":"51","author":"Behnia","year":"1999","journal-title":"J Pharm Pharmacol"},{"key":"10.1124\/dmd.31.4.462_bib2","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1006\/taap.1993.1023","article-title":"Daunorubicin-induced cardiac injury in the rabbit: a role for daunorubicinol?","volume":"118","author":"Cusack","year":"1993","journal-title":"Toxicol Appl Pharmacol"},{"year":"1997","series-title":"ADAPT II User\u2019s Guide: Pharmacokinetic\/Pharmacodynamic Systems Analysis Software.","author":"D\u2019Argenio","key":"10.1124\/dmd.31.4.462_bib3"},{"key":"10.1124\/dmd.31.4.462_bib4","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0009-2797(00)00196-4","article-title":"Carbonyl reductase.","volume":"129","author":"Forrest","year":"2000","journal-title":"Chem Biol Interact"},{"key":"10.1124\/dmd.31.4.462_bib5","first-page":"5158","article-title":"Human carbonyl reductase overexpression in the heart advances the development of doxorubicin-induced cardiotoxicity in transgenic mice.","volume":"60","author":"Forrest","year":"2000","journal-title":"Cancer Res"},{"key":"10.1124\/dmd.31.4.462_bib6","first-page":"1929","article-title":"Nitric oxide synthases catalyze the activation of redox cycling and bioreductive anticancer agents.","volume":"59","author":"Garner","year":"1999","journal-title":"Cancer Res"},{"key":"10.1124\/dmd.31.4.462_bib7","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0014-2999(87)90360-8","article-title":"Barbiturate inhibition of endothelium-dependent dilatation of blood- and Krebs-perfused rat tail arteries.","volume":"34","author":"Gerkens","year":"1987","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/dmd.31.4.462_bib8","series-title":"Statistical Tools for Nonlinear Regression","first-page":"69","author":"Huet","year":"1996"},{"key":"10.1124\/dmd.31.4.462_bib9","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1023\/A:1013022212738","article-title":"Influence of P-glycoprotein modulators on cardiac uptake, metabolism and effects of idarubicin.","volume":"18","author":"Kang","year":"2001","journal-title":"Pharm Res (NY)"},{"key":"10.1124\/dmd.31.4.462_bib10","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1023\/A:1022246708326","article-title":"Kinetic analysis of saturable myocardial uptake of idarubicin in rat heart. Effect of doxorubicin and hypothermia.","volume":"20","author":"Kang","year":"2003","journal-title":"Pharm Res (NY)"},{"key":"10.1124\/dmd.31.4.462_bib11","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1053\/sonc.2001.26431","article-title":"Anthracycline-induced cardiomyopathy.","volume":"4","author":"Keefe","year":"2001","journal-title":"Semin Oncol"},{"key":"10.1124\/dmd.31.4.462_bib12","first-page":"R665","article-title":"Multiexponential, multicompartmental and noncompartmental modeling. II. Data analysis and statistical considerations.","volume":"246","author":"Landaw","year":"1984","journal-title":"Am J Physiol"},{"key":"10.1124\/dmd.31.4.462_bib13","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1021\/tx000013q","article-title":"Doxorubicin metabolism and toxicity in human myocardium: role of cytoplasmic deglycosidation and carbonyl reduction.","volume":"13","author":"Licata","year":"2000","journal-title":"Chem Res Toxicol"},{"key":"10.1124\/dmd.31.4.462_bib14","doi-asserted-by":"crossref","first-page":"H254","DOI":"10.1152\/ajpheart.01023.2001","article-title":"Melatonin as an effective protector against doxorubicin-induced cardiotoxicity.","volume":"283","author":"Liu","year":"2002","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1124\/dmd.31.4.462_bib15","first-page":"593","article-title":"Comparative mammalian metabolism of adriamycin and daunorubicin.","volume":"38","author":"Loveless","year":"1978","journal-title":"Cancer Res"},{"key":"10.1124\/dmd.31.4.462_bib16","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/BF02353864","article-title":"Comparison of the Akaike information criteria, the Schwarz criterion and the F test as guides to model selection.","volume":"22","author":"Ludden","year":"1994","journal-title":"J Pharmacokinet Biopharm"},{"key":"10.1124\/dmd.31.4.462_bib17","first-page":"E409","article-title":"Use of residence time moments in compartmental analysis.","volume":"249","author":"Matis","year":"1985","journal-title":"Am J Physiol"},{"key":"10.1124\/dmd.31.4.462_bib18","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1172\/JCI117833","article-title":"Secondary alcohol metabolites mediate iron delocalization in cytosolic fractions of myocardial biopsies exposed to anticancer anthracyclines. Novel linkage between anthracycline metabolism and iron-induced cardiotoxicity.","volume":"95","author":"Minotti","year":"1995","journal-title":"J Clin Investig"},{"key":"10.1124\/dmd.31.4.462_bib19","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1038\/sj.bjp.0704369","article-title":"Impairment of myocardial contractility by anticancer anthracyclines: role of secondary alcohol metabolites and evidence of reduced toxicity by a novel disaccharide analogue.","volume":"134","author":"Minotti","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1124\/dmd.31.4.462_bib20","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1096\/fasebj.12.7.541","article-title":"The secondary alcohol metabolite of doxorubicin irreversibly inactivates aconitase\/iron regulatory protein-1 in cytosolic fractions from human myocardium.","volume":"12","author":"Minotti","year":"1998","journal-title":"FASEB J"},{"key":"10.1124\/dmd.31.4.462_bib21","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1096\/fasebj.4.13.2210154","article-title":"Doxorubicin cardiotoxicity: analysis of prevailing hypotheses.","volume":"4","author":"Olson","year":"1990","journal-title":"FASEB J"},{"key":"10.1124\/dmd.31.4.462_bib22","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1097\/00001813-199908000-00007","article-title":"Comparative cardiotoxicity of idarubicin and doxorubicin using the isolated perfused rat heart model.","volume":"10","author":"Platel","year":"1999","journal-title":"Anti-Cancer Drugs"},{"key":"10.1124\/dmd.31.4.462_bib23","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s004320050019","article-title":"In vitro effect of multidrug resistance modifiers on idarubicinol efflux in blasts of acute myeloid leukemia.","volume":"126","author":"Schroder","year":"2000","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1124\/dmd.31.4.462_bib24","first-page":"842","article-title":"Myocardial effects of flavonoids from Crataegus species.","volume":"45","author":"Schussler","year":"1995","journal-title":"Arzneim-Forsch"},{"key":"10.1124\/dmd.31.4.462_bib25","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/sj.leu.2401996","article-title":"Cyclosporin increases cellular idarubicin and idarubicinol concentrations in relapsed or refractory AML mainly due to reduced systemic clearance.","volume":"15","author":"Smeets","year":"2001","journal-title":"Leukemia (Baltimore)"},{"key":"10.1124\/dmd.31.4.462_bib26","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/S0022-3565(25)11114-2","article-title":"Impaired biliary excretion of acetaminophen glucuronide in the isolated perfused rat liver after acute phenobarbital treatment and in vivo phenobarbital pretreatment.","volume":"261","author":"Studenberg","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.31.4.462_bib27","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1213\/00000539-199405000-00001","article-title":"Barbiturates inhibit endothelium-dependent and independent relaxations mediated by cyclic GMP.","volume":"78","author":"Terasako","year":"1994","journal-title":"Anesth Analg"},{"key":"10.1124\/dmd.31.4.462_bib28","first-page":"2279","article-title":"Dose-finding and pharmacologic study of chronic oral idarubicin therapy in metastatic breast cancer patients.","volume":"6","author":"Toffoli","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1124\/dmd.31.4.462_bib29","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1124\/jpet.300.2.688","article-title":"P-glycoprotein inhibitors enhance saturable uptake of idarubicin in rat heart: pharmacokinetic\/pharmacodynamic modeling.","volume":"300","author":"Weiss","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.31.4.462_bib30","first-page":"670","article-title":"The anthracyclines: will we ever find a better doxorubicin?","volume":"19","author":"Weiss","year":"1992","journal-title":"Semin Oncol"},{"key":"10.1124\/dmd.31.4.462_bib31","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1177\/40.12.1453004","article-title":"Immunohistochemical localization of carbonyl reductase in human tissues.","volume":"40","author":"Wirth","year":"1992","journal-title":"J Histochem Cytochem"},{"key":"10.1124\/dmd.31.4.462_bib32","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1124\/dmd.30.9.962","article-title":"Mechanisms of impaired biliary excretion of acetaminophen glucuronide after acute phenobarbital treatment or phenobarbital pretreatment.","volume":"30","author":"Xiong","year":"2002","journal-title":"Drug Metab Dispos"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624026515?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624026515?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.31.4.462","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T15:10:34Z","timestamp":1739891434000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624026515"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,4]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2003,4]]}},"alternative-id":["S0090955624026515"],"URL":"https:\/\/doi.org\/10.1124\/dmd.31.4.462","relation":{},"ISSN":["0090-9556"],"issn-type":[{"type":"print","value":"0090-9556"}],"subject":[],"published":{"date-parts":[[2003,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modeling the Metabolism of Idarubicin to Idarubicinol in Rat Heart: Effect of Rutin and Phenobarbital","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.31.4.462","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2003 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}